Cases of blood cancer are increasing among Indian youth, information came in Lancet report, know what are the symptoms

What the Lancet study revealed

CML affects a large number of people worldwide. It is estimated to affect 1.2 to 1.5 million individuals. Despite its prevalence, CML is relatively rare compared to other forms of leukemia. It accounts for about 15 percent of all leukemia cases. A recent study published in the journal Lancet showed that the disease is affecting much younger individuals. In India, most patients are diagnosed between the ages of 30 and 40. In comparison, in Western countries it is diagnosed at an average age of 64 years.

If you are taking these two medicines, you may suffer from stomach paralysis! If you are trying to lose weight fast, be careful

5-10 new patients every month

KS Nataraj, senior hematologist and hemato-oncologist at HCG Comprehensive Cancer Care Hospital in Bengaluru, said that I see about 5-10 new patients suffering from CML every month. At the same time, 10-15 additional patients come for follow-up. He said that the number of patients is also increasing because people are not aware of this disease. When people go for routine general checkup and the doctor recommends tests, a suspiciously high WBC count is detected.

What is the new flirt variant of corona virus? Infection increased in many countries of the world, know everything

These are the symptoms of the disease

CML is largely curable if diagnosed and treated in time. Common symptoms of CML include sweating, weight loss, fever, bone pain and enlarged spleen. Tulika Seth, Professor of Hematology at AIIMS New Delhi, told IANS, “Chronic myeloid leukemia is curable. However, fighting this disease requires a very delicate balance. Consistent medication and regular check-ups are the most important things to recover from this disease. With monitoring and personalised treatment strategies, CML can be recovered.

Slow poison dissolved in air can give you type 2 diabetes, what the latest study says
He added that each stage of CML treatment presents unique challenges. It is important to embrace progress in treatment by prioritising treatment compliance with frequent monitoring.